Oxford Biomedica PLC 2015 Annual Report with Sustainability Disclosures
Company: Oxford Biomedica PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2015
Type: Annual Report with Sustainability Disclosures
Pages: 120
The report describes Oxford BioMedica's 2015 expansion as it developed its gene and cell therapy platform, with gross income growing 28% to £18.8 million and headcount reaching 231. Expanded production capacity and upgraded facilities supported partner work and internal programmes. Its corporate responsibility section covers patient and employee safety, community impacts, and environmental monitoring, including estimated total CO2 emissions of 2,819 tonnes.
Indicators available in this report: